Daniel Loeb's hedge-fund Third Point LLC added sizeable new stakes in companies including American Airlines Group Inc. (AAL), Anheuser-Busch InBev NV (BUD) and Verizon Communications Inc. (VZ), according to a regulatory filing Thursday.

The hedge-fund manager, who recently settled a seven-month-long battle with art auction house Sotheby's (BID), disclosed he held at the end of March 2.7 million shares of American Airlines, 1.4 million shares of Anheuser-Busch and 3.5 million shares of Verizon worth about $166 million.

The New York hedge fund also revealed new stakes in Avago Technologies Ltd. (AVGO), CF Industries Holdings Inc. (CF) and the Industrial Select Sector SPDR Fund (XLI), an exchange-traded fund that provides exposure to the industrial sector for the S&P500. Its stake in the industrials ETF was worth about $262 million, according to the filing.

Third Point exited positions it held at the end of 2013 in Abbott Laboratories (ABT), BlackBerry Ltd. (BBRY), Gilead Sciences Inc. (GILD) and Yahoo Inc. (YHOO) and increased its stakes in Liberty Global PLC (LBTYA) and Actavis PLC (ACT). Actavis in the first quarter agreed to acquire rival drug maker Forest Laboratories Inc. (FRX).

Third Point had other pharmaceuticals bets, according to the filing, holding a small stake worth about $33 million in Valeant Pharmaceuticals International Inc. (VRX), which had teamed up with hedge-fund manager William Ackman to try to buy Allergan Inc. (AGN). Allergan formally rejected the hostile takeover bid earlier this month.

Third Point decreased its stake in American International Group Inc. (AIG) to 7 million, down from 12.5 million shares at the end of 2013.

Write to Juliet Chung at Juliet.Chung@wsj.com

Access Investor Kit for Anheuser-Busch InBev SA

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=BE0003793107

Access Investor Kit for Valeant Pharmaceuticals International, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=CA91911K1021

Access Investor Kit for Avago Technologies Ltd.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=SG9999006241

Access Investor Kit for Abbott Laboratories

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US0028241000

Access Investor Kit for Allergan, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US0184901025

Access Investor Kit for American International Group, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US0268747849

Access Investor Kit for Anheuser-Busch InBev SA

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US03524A1088

Access Investor Kit for CF Industries Holdings, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US1252691001

Access Investor Kit for Forest Laboratories, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US3458381064

Access Investor Kit for Gilead Sciences, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US3755581036

Access Investor Kit for Sotheby's

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US8358981079

Access Investor Kit for Verizon Communications, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US92343V1044

Access Investor Kit for Yahoo!, Inc.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US9843321061

Subscribe to WSJ: http://online.wsj.com?mod=djnwires